$BSGM
BioSig Technologies, Inc. Stock $bsgm

$bsgm Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223041256 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$12.00K	$1.000K	$135.0K
YoY Change	-91.11%	-99.26%	25.0%
Cost Of Revenue	$0.00		$30.00K
YoY Change	-100.0%		-21.05%
Gross Profit	$12.00K	$1.000K	$105.0K
YoY Change	-88.89%	-99.05%	50.0%
Gross Profit Margin	100.0%	100.0%	77.78%
Selling, General & Admin	$4.910M	$2.820M	$4.774M
YoY Change	-16.82%	-40.93%	-26.61%
% of Gross Profit	40916.67%	282000.0%	4546.67%
Research & Development	$1.176M	$1.100M	$1.700M
YoY Change	5.0%	-35.29%	29.28%
% of Gross Profit	9800.0%	110000.0%	1619.05%
Depreciation & Amortization	$91.00K	$92.00K	$84.00K
YoY Change	9.64%	9.52%	64.71%
% of Gross Profit	758.33%	9200.0%	80.0%
Operating Expenses	$6.179M	$4.052M	$6.591M
YoY Change	-13.05%	-38.52%	-16.26%
Operating Profit	-$6.167M	-$4.051M	-$6.486M
YoY Change	-11.87%	-37.54%	-16.86%
Interest Expense	$1.000K	$0.00	$1.000K
YoY Change	-50.0%	-100.0%	0.0%
% of Operating Profit
Other Income/Expense, Net	$38.00K
YoY Change
Pretax Income	-$6.128M	-$4.050M	-$6.485M
YoY Change	-12.41%	-37.55%	-10.51%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$6.051M	-$4.567M	-$6.372M
YoY Change	-14.11%	-28.33%	-12.15%
Net Earnings / Revenue	-50425.0%	-456700.0%	-4720.0%
Basic Earnings Per Share		-$0.06	-$0.14
Diluted Earnings Per Share	-$0.70	-$0.06	-$141.6K
COMMON SHARES
Basic Shares Outstanding	88.11M shares	74.93M shares	44.81M shares
Diluted Shares Outstanding		75.37M shares	45.02M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$293.0K	$490.0K	$937.0K
YoY Change	-36.03%	-47.71%	-94.66%
Cash & Equivalents	$200.0K	$400.0K	$900.0K
Short-Term Investments	$103.0K	$100.0K	$50.00K
Other Short-Term Assets	$211.0K	$330.0K	$456.0K
YoY Change	-35.08%	-27.63%	-5.59%
Inventory	$0.00	$219.0K	$1.691M
Prepaid Expenses	$206.0K	$322.0K	$456.0K
Receivables	$24.00K	$14.00K	$5.000K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$528.0K	$1.051M	$3.089M
YoY Change	-53.19%	-65.98%	-84.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$921.0K	$593.0K	$685.0K
YoY Change	38.5%	-13.43%	-45.2%
Goodwill
YoY Change
Intangibles	$1.000K	$1.000K	$1.00
YoY Change	0.0%	99900.0%
Long-Term Investments	$17.00K	$40.00K	$66.00K
YoY Change	-85.83%	-39.39%
Other Assets	$43.00K	$687.0K	$44.00K
YoY Change	-2.27%	1461.36%	-52.17%
Total Long-Term Assets	$1.270M	$2.103M	$1.926M
YoY Change	-57.41%	9.19%	15.05%
TOTAL ASSETS
Total Short-Term Assets	$528.0K	$1.051M	$3.089M
Total Long-Term Assets	$1.270M	$2.103M	$1.926M
Total Assets	$1.798M	$3.154M	$5.015M
YoY Change	-56.25%	-37.11%	-76.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$4.465M	$3.810M	$2.438M
YoY Change	41.07%	56.28%	-0.89%
Deferred Revenue	$16.00K	$4.000K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.582M	$3.911M	$2.540M
YoY Change	40.51%	53.98%	-1.21%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$103.0K	$190.0K	$536.0K
YoY Change	-77.21%	-64.55%	27.01%
Total Long-Term Liabilities	$103.0K	$193.0K	$536.0K
YoY Change	-77.21%	-63.99%	27.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.582M	$3.911M	$2.540M
Total Long-Term Liabilities	$103.0K	$193.0K	$536.0K
Total Liabilities	$4.711M	$4.104M	$3.076M
YoY Change	26.88%	33.42%	-10.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$245.0M	-$239.0M	-$209.0M
YoY Change	13.45%	14.33%
Common Stock	$9.000K	$79.00K	$46.00K
YoY Change	-83.64%	71.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.913M	-$1.160M	$1.822M
YoY Change
Total Liabilities & Shareholders Equity	$1.798M	$3.154M	$5.015M
YoY Change	-56.25%	-37.11%	-76.86%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$6.051M	-$4.567M	-$6.372M
YoY Change	-14.11%	-28.33%	-12.15%
Depreciation, Depletion And Amortization	$91.00K	$92.00K	$84.00K
YoY Change	9.64%	9.52%	64.71%
Cash From Operating Activities	-$2.943M	-$3.830M	-$4.947M
YoY Change	-28.46%	-22.58%	-26.8%
INVESTING ACTIVITIES
Capital Expenditures	$6.000K	$60.00K	-$50.00K
YoY Change	-89.66%	-220.0%	-76.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$6.000K	-$60.00K	-$50.00K
YoY Change	-89.66%	20.0%	-76.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.742M	3.030M	807.0K
YoY Change	-24.71%	275.46%	-91.04%
NET CHANGE
Cash From Operating Activities	-2.943M	-3.830M	-4.947M
Cash From Investing Activities	-6.000K	-60.00K	-50.00K
Cash From Financing Activities	2.742M	3.030M	807.0K
Net Change In Cash	-207.0K	-860.0K	-4.190M
YoY Change	-60.94%	-79.47%	-306.3%
FREE CASH FLOW
Cash From Operating Activities	-$2.943M	-$3.830M	-$4.947M
Capital Expenditures	$6.000K	$60.00K	-$50.00K
Free Cash Flow	-$2.949M	-$3.890M	-$4.897M
YoY Change	-29.31%	-20.56%	-25.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001530766
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent		usd
CY2023Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent		usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2023Q2	BSGM	Stock Issued During Period Value Common Stock Issued For Exercise Of Warrants Cashlessly StockIssuedDuringPeriodValueCommonStockIssuedForExerciseOfWarrantsCashlessly		usd
CY2022Q2	BSGM	Adjustments To Additional Paid In Capital Issuance Of Subsidiary Stock In Settlement Of Debt To Parent AdjustmentsToAdditionalPaidInCapitalIssuanceOfSubsidiaryStockInSettlementOfDebtToParent		usd
	us-gaap	Inventory Write Down InventoryWriteDown		usd
	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment		usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges		usd
	BSGM	Increase Decrease Customer Deposits IncreaseDecreaseCustomerDeposits		usd
	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1		usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2023Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue		usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent		usd
CY2023Q3	us-gaap	Deferred Costs DeferredCosts		usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent		usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2023Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent		usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets		usd
	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue		usd
CY2021Q4	us-gaap	Sales Type Lease Net Investment In Lease SalesTypeLeaseNetInvestmentInLease		usd
	us-gaap	Sales Type Lease Interest Income Lease Receivable SalesTypeLeaseInterestIncomeLeaseReceivable		usd
CY2023Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent		usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P5Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q3	BSGM	Class Of Warrant Or Rights Outstanding Intrinsic Value ClassOfWarrantOrRightsOutstandingIntrinsicValue		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38659
	dei	Entity Registrant Name EntityRegistrantName	BIOSIG TECHNOLOGIES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-4333375
	dei	Entity Address Address Line1 EntityAddressAddressLine1	55 Greens Farms Road, 1st Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	Westport
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06880
	dei	City Area Code CityAreaCode	(203)
	dei	Local Phone Number LocalPhoneNumber	409-5444
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	BSGM
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	88107565	shares
CY2023Q3	us-gaap	Cash Cash	389000	usd
CY2022Q4	us-gaap	Cash Cash	357000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	219000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	336000	usd
CY2023Q3	us-gaap	Deferred Costs Current DeferredCostsCurrent	5000	usd
CY2023Q3	us-gaap	Sales Type Lease Lease Receivable SalesTypeLeaseLeaseReceivable	102000	usd
CY2022Q4	us-gaap	Sales Type Lease Lease Receivable SalesTypeLeaseLeaseReceivable	101000	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	322000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	325000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1051000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1128000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	593000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	665000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	487000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	705000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1141000	usd
CY2023Q3	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	43000	usd
CY2022Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	120000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	293000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	307000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	687000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	44000	usd
CY2023Q3	us-gaap	Assets Assets	3154000	usd
CY2022Q4	us-gaap	Assets Assets	4110000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3470000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2852000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5000	usd
CY2023Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	98000	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	91000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	339000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	313000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3911000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3261000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	193000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	452000	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	193000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	452000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	4104000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3713000	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	105000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	105000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79243833	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79243833	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54610638	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54610638	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	79000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	55000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	237727000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	216232000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-238966000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-215974000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-1160000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	313000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	105000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-21000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1055000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	292000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3154000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4110000	usd
CY2023Q3	us-gaap	Revenues Revenues	1000	usd
CY2022Q3	us-gaap	Revenues Revenues	135000	usd
	us-gaap	Revenues Revenues	6000	usd
	us-gaap	Revenues Revenues	151000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	30000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	30000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	105000	usd
	us-gaap	Gross Profit GrossProfit	6000	usd
	us-gaap	Gross Profit GrossProfit	121000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1145000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1733000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3916000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4701000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2815000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4774000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18167000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15477000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	92000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	84000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	268000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	210000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	4052000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	6591000	usd
	us-gaap	Operating Expenses OperatingExpenses	22351000	usd
	us-gaap	Operating Expenses OperatingExpenses	20388000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4051000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6486000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-22345000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20267000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-225000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4050000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6485000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22562000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20266000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-4050000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-6485000	usd
	us-gaap	Profit Loss ProfitLoss	-22562000	usd
	us-gaap	Profit Loss ProfitLoss	-20266000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	517000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-113000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	430000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-172000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4567000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6372000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22992000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-20094000	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2000	usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	7000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	7000	usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	17000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	125000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1601000	usd
CY2022Q1	BSGM	Adjustments To Additional Paid In Capital Change In Fair Value Of Modified Options AdjustmentsToAdditionalPaidInCapitalChangeInFairValueOfModifiedOptions	15000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4569000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6391000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22999000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20226000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75372373	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75372373	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45015574	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45015574	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69077898	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69077898	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40311669	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40311669	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	292000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1097000	usd
CY2023Q1	BSGM	Stock Issued During Period Value Issued In Settlement Of Debt StockIssuedDuringPeriodValueIssuedInSettlementOfDebt	105000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	482000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	6748000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1052000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7382000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1910000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4811000	usd
CY2023Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	201000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3245000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	1567000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-69000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-11130000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	331000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	937000	usd
CY2023Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	237000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2624000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-3000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	404000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-1296000	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-4050000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1055000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12460000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3002000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	399000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-8065000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9410000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	483000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	302000	usd
CY2022Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	438000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2818000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2818000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-317000	usd
CY2022Q2	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	108000	usd
CY2022Q2	BSGM	Deemed Preferred Stock Dividend DeemedPreferredStockDividend	108000	usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-5716000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6977000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6977000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	807000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	807000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	537000	usd
CY2022Q3	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	17000	usd
CY2022Q3	BSGM	Deemed Preferred Stock Dividend DeemedPreferredStockDividend	17000	usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-6485000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1834000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1834000	usd
	us-gaap	Profit Loss ProfitLoss	-22562000	usd
	us-gaap	Profit Loss ProfitLoss	-20266000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	268000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	210000	usd
	BSGM	Non Cash Lease Expense NonCashLeaseExpense	216000	usd
	BSGM	Non Cash Lease Expense NonCashLeaseExpense	244000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1307000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6532000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2703000	usd
	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	-15000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5000	usd
	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-75000	usd
	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	114000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	16000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	49000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-70000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	625000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	104000	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	4000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-5000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-24000	usd
	BSGM	Increase Decrease Customer Deposits IncreaseDecreaseCustomerDeposits	4000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	724000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-87000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-231000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-233000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14371000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17591000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	182000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	110000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-182000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-110000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12617000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5820000	usd
	BSGM	Proceeds From Proceeds From Sale Of Common Stock Under A At The Market Offerings Net Of Issuance Costs ProceedsFromProceedsFromSaleOfCommonStockUnderAAtTheMarketOfferingsNetOfIssuanceCosts	-3000	usd
	BSGM	Proceeds From Proceeds From Sale Of Common Stock Under A At The Market Offerings Net Of Issuance Costs ProceedsFromProceedsFromSaleOfCommonStockUnderAAtTheMarketOfferingsNetOfIssuanceCosts	1109000	usd
	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	1971000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14585000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6929000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	32000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-10772000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	357000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11659000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	389000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	887000	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	105000	usd
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	7000	usd
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	7000	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	125000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	502000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	400000	usd
CY2023Q3	BSGM	Working Capital Deficit WorkingCapitalDeficit	2900000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14400000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zt2P3DPIwll4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zG1mQ3w59eRd">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4333	usd
CY2022Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P30M
CY2022Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P1Y
CY2022	BSGM	Lessor Sales Type Lease Discount Rate LessorSalesTypeLeaseDiscountRate	0.02	pure
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	5000	usd
CY2023Q3	us-gaap	Deferred Costs Current DeferredCostsCurrent	5000	usd
CY2023Q3	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	5000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1526000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1477000	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1307000	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	219000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1477000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zIbtBLuh9yya" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_z93nSQaHkz26">Concentrations of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents. The Company places its cash and temporary cash investments with credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limit. At September 30, 2023 and December 31, 2022, deposits in excess of FDIC limits were $<span id="xdx_90A_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20230930_zvdzRzvSFKq5" title="Cash, uninsured amount">0.2</span> million and $<span id="xdx_901_eus-gaap--CashUninsuredAmount_iI_pn4n6_c20221231_zDc2XOrUOQUh" title="Cash, uninsured amount">0.05</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	200000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	50000.00	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	219000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	336000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1141000	usd
CY2023Q3	BSGM	Allowance For Inventory AllowanceForInventory	1307	usd
CY2023Q3	us-gaap	Deposit Assets DepositAssets	643000	usd
CY2023Q3	us-gaap	Security Deposit SecurityDeposit	43000	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	43000	usd
CY2023Q3	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	1000	usd
CY2022Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	1000	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	687000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	44000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1100000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3900000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1700000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4700000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19101187	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8829876	shares
CY2023Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	4751	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	14354	usd
CY2022Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	4751	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	14354	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1448000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1266000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	855000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	601000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	593000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	665000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	87338	usd
	us-gaap	Depreciation Depreciation	253486	usd
CY2022Q3	us-gaap	Depreciation Depreciation	79312	usd
	us-gaap	Depreciation Depreciation	195937	usd
	BSGM	Number Of Leases NumberOfLeases	2	integer
CY2023Q3	BSGM	Operating Lease Right To Use Assets Gross OperatingLeaseRightToUseAssetsGross	995000	usd
CY2022Q4	BSGM	Operating Lease Right To Use Assets Gross OperatingLeaseRightToUseAssetsGross	995000	usd
CY2023Q3	BSGM	Operating Lease Right To Use Asset Accumulated Depreciation OperatingLeaseRightToUseAssetAccumulatedDepreciation	508000	usd
CY2022Q4	BSGM	Operating Lease Right To Use Asset Accumulated Depreciation OperatingLeaseRightToUseAssetAccumulatedDepreciation	290000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	487000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	705000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	95964	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	280541	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	116725	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	333071	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	532000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	765000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	339000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	313000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	193000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	452000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	90000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	370000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	106000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	566000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	34000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	532000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	84000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	78000	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	8000	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	4000	usd
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	29000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	96000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	117000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	252000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	244000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	22000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	28000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	7000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	61000	usd
	us-gaap	Lease Cost LeaseCost	281000	usd
	us-gaap	Lease Cost LeaseCost	333000	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	4333	usd
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P30M
CY2022Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P1Y
CY2022Q3	BSGM	Lessor Sales Type Lease Discount Rate LessorSalesTypeLeaseDiscountRate	0.02	pure
CY2022Q4	us-gaap	Sales Type Lease Net Investment In Lease SalesTypeLeaseNetInvestmentInLease	221000	usd
	BSGM	Sales Type Lease Invoiced To Customer SalesTypeLeaseInvoicedToCustomer	-81000	usd
	us-gaap	Sales Type Lease Interest Income Lease Receivable SalesTypeLeaseInterestIncomeLeaseReceivable	2000	usd
CY2023Q3	us-gaap	Sales Type Lease Unguaranteed Residual Asset SalesTypeLeaseUnguaranteedResidualAsset	3000	usd
CY2023Q3	us-gaap	Sales Type Lease Net Investment In Lease SalesTypeLeaseNetInvestmentInLease	145000	usd
	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	127000	usd
	BSGM	Sales Type Lease Invoiced To Customer SalesTypeLeaseInvoicedToCustomer	-13000	usd
CY2022Q3	us-gaap	Sales Type Lease Net Investment In Lease SalesTypeLeaseNetInvestmentInLease	114000	usd
CY2023Q3	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths	26000	usd
CY2023Q3	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears	104000	usd
CY2023Q3	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears	13000	usd
CY2023Q3	us-gaap	Sales Type Lease Unguaranteed Residual Asset SalesTypeLeaseUnguaranteedResidualAsset	3000	usd
CY2023Q3	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	146000	usd
CY2023Q3	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount	1000	usd
CY2023Q3	us-gaap	Sales Type Lease Net Investment In Lease SalesTypeLeaseNetInvestmentInLease	145000	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1303000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	646000	usd
CY2023Q3	BSGM	Accrued Reimbursements Current AccruedReimbursementsCurrent	25000	usd
CY2022Q4	BSGM	Accrued Reimbursements Current AccruedReimbursementsCurrent	33000	usd
CY2023Q3	BSGM	Accrued Consulting Current AccruedConsultingCurrent	527000	usd
CY2022Q4	BSGM	Accrued Consulting Current AccruedConsultingCurrent	546000	usd
CY2023Q3	BSGM	Accrued Research And Development Expenses AccruedResearchAndDevelopmentExpenses	601000	usd
CY2022Q4	BSGM	Accrued Research And Development Expenses AccruedResearchAndDevelopmentExpenses	625000	usd
CY2023Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	281000	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	256000	usd
CY2023Q3	BSGM	Accrued Office Expense And Other Expense AccruedOfficeExpenseAndOtherExpense	141000	usd
CY2022Q4	BSGM	Accrued Office Expense And Other Expense AccruedOfficeExpenseAndOtherExpense	220000	usd
CY2023Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	592000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	513000	usd
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	13000	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3470000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2852000	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022	BSGM	Deemed Preferred Stock Dividend DeemedPreferredStockDividend	209682	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79243833	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79243833	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54610638	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54610638	shares
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	8894846	shares
CY2022	BSGM	Stock Issued During Period Value Issued For Services Fair Value StockIssuedDuringPeriodValueIssuedForServicesFairValue	1060740	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	105000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	689233	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.8246
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P6M
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5304651	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M12D
CY2023Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	3571174	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4555484	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.49
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3000000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1229500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.33
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P10Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	480333	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5304651	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.90
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M12D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	13395000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3571174	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.59
	BSGM	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3	P6Y2M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	13395000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice	0.4893
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1229500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.33
	BSGM	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P10Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0	pure
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.03
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	502662	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1142185	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	416906	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1423292	usd
CY2023Q3	BSGM	Unrecognized Compensation Expense UnrecognizedCompensationExpense	1391743	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y7M9D
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	12349645	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	689233	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.8381
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	43601	shares
CY2022Q4	BSGM	Class Of Warrant Or Rights Outstanding Intrinsic Value ClassOfWarrantOrRightsOutstandingIntrinsicValue	3960000	usd
	BSGM	Class Of Warrants Or Right Issued ClassOfWarrantsOrRightIssued	8193510	shares
	BSGM	Warrants Granted Weighted Average Remaining Contractual Term WarrantsGrantedWeightedAverageRemainingContractualTerm	P5Y2M12D
	BSGM	Class Of Warrants Or Right Exercised ClassOfWarrantsOrRightExercised	-60976	shares
CY2023Q3	BSGM	Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding	1.20
	BSGM	Warrants Outstanding Weighted Average Remaining Contractual Term WarrantsOutstandingWeightedAverageRemainingContractualTerm	P4Y7M6D
	BSGM	Warrants Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term WarrantsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm	P4Y7M6D
CY2023Q3	BSGM	Class Of Warrant Or Rights Vested And Expected To Vest Outstanding Intrinsic Value ClassOfWarrantOrRightsVestedAndExpectedToVestOutstandingIntrinsicValue	70170000	usd
	BSGM	Warrants Exercisable Weighted Average Remaining Contractual Term WarrantsExercisableWeightedAverageRemainingContractualTerm	P4Y3M18D
CY2023Q3	BSGM	Class Of Warrant Or Rights Exercisable Intrinsic Value ClassOfWarrantOrRightsExercisableIntrinsicValue	70170000	usd
CY2023Q3	us-gaap	Share Price SharePrice	0.4893
CY2023Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	260000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	vesting quarterly over one year
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	301600	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	300000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	vesting quarterly over one year
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	190920	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	172717	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	379243	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	105092	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	246633	usd
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward	the exercise price of an Incentive Stock Option should not be less than 110% of fair market value of the common stock at the date of the grant for a 10% or more stockholder and 100% of fair market value for a grantee who is not 10% stockholder.
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2650071	shares
CY2023Q3	BSGM	Net Income Loss Of Non Controlling Interest NetIncomeLossOfNonControllingInterest	1474000	usd
CY2023Q3	BSGM	Average Noncontrolling Interest Percentage Of Profitlosses AverageNoncontrollingInterestPercentageOfProfitlosses	0.35	pure
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	517000	usd
CY2022Q3	BSGM	Net Income Loss Of Non Controlling Interest NetIncomeLossOfNonControllingInterest	-365000	usd
CY2022Q3	BSGM	Average Noncontrolling Interest Percentage Of Profitlosses AverageNoncontrollingInterestPercentageOfProfitlosses	0.31	pure
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-113000	usd
	BSGM	Net Income Loss Of Non Controlling Interest NetIncomeLossOfNonControllingInterest	1176000	usd
	BSGM	Average Noncontrolling Interest Percentage Of Profitlosses AverageNoncontrollingInterestPercentageOfProfitlosses	0.37	pure
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	430000	usd
	BSGM	Net Income Loss Of Non Controlling Interest NetIncomeLossOfNonControllingInterest	-550000	usd
	BSGM	Average Noncontrolling Interest Percentage Of Profitlosses AverageNoncontrollingInterestPercentageOfProfitlosses	0.31	pure
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-172000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-172000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-21000	usd
	us-gaap	Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Issuance Of Equity By Subsidiary To Noncontrolling Interests ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesIssuanceOfEquityBySubsidiaryToNoncontrollingInterests	296000	usd
	us-gaap	Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent	600000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	430000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	105000	usd
CY2023Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	56078	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	185815	usd
CY2022Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	57044	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	192572	usd
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	2554136	usd
CY2023Q3	us-gaap	Revenues Revenues	1000	usd
CY2022Q3	us-gaap	Revenues Revenues	135000	usd
	us-gaap	Revenues Revenues	6000	usd
	us-gaap	Revenues Revenues	151000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	4052000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	6591000	usd
	us-gaap	Operating Expenses OperatingExpenses	22351000	usd
	us-gaap	Operating Expenses OperatingExpenses	20388000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4051000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6486000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-22345000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20267000	usd
CY2023Q3	us-gaap	Assets Assets	3154000	usd
CY2022Q4	us-gaap	Assets Assets	4110000	usd

Files In Submission

Name	View Source	Status
0001493152-23-041256-index-headers.html	Edgar Link	pending
0001493152-23-041256-index.html	Edgar Link	pending
0001493152-23-041256.txt	Edgar Link	pending
0001493152-23-041256-xbrl.zip	Edgar Link	pending
bsgm-20230930.xsd	Edgar Link	pending
ex31-01.htm	Edgar Link	pending
ex31-02.htm	Edgar Link	pending
ex32-01.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
bsgm-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bsgm-20230930_lab.xml	Edgar Link	unprocessable
bsgm-20230930_cal.xml	Edgar Link	unprocessable
bsgm-20230930_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BSGM
BioSig Technologies, Inc. Stock $bsgm

2023 Q4 Form 10-Q Financial Statement

#000149315223041256 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BSGM BioSig Technologies, Inc. Stock $bsgm

2023 Q4 Form 10-Q Financial Statement

#000149315223041256 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BSGM
BioSig Technologies, Inc. Stock $bsgm